---
title: "Cryo-Cell net income rises to $555,000 in FY26 Q2; revenue slips 2% to $7.8 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292813653.md"
description: "Cryo-Cell reported fiscal Q2 2026 net income of $555,000 ($0.07 per share), up from $356,000 in the prior year period. Revenue declined 2% to $7.8 million, primarily due to a drop in processing and storage fee revenue to $7.71 million. Public banking revenue rose slightly to $46,000, while product revenue remained flat at $14,000."
datetime: "2026-07-15T20:30:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292813653.md)
  - [en](https://longbridge.com/en/news/292813653.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292813653.md)
generator: "portal-rs"
---

# Cryo-Cell net income rises to $555,000 in FY26 Q2; revenue slips 2% to $7.8 million

-   Cryo-Cell posted fiscal Q2 2026 revenue of USD 7.8 million, down 2% from the year-earlier quarter. \* Net income rose to USD 555,000, or USD 0.07 per share, from USD 356,000, or USD 0.04 per share. \* Processing and storage fee revenue slipped to USD 7.71 million; public banking revenue increased to USD 46,000. \* Product revenue was flat at USD 14,000, while the quarter’s revenue decline was driven by lower processing and storage fees. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260715354031) on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CCEL.US](https://longbridge.com/en/quote/CCEL.US.md)

## Related News & Research

- [CRYO CELL INTERNATIONAL 3Q FY2026: Revenue $7.82M, 10-Q Summary](https://longbridge.com/en/news/301438966.md)
- [CCEL: Revenue and net income declined, with expansion paused due to Duke arbitration and NYSE compliance risks](https://longbridge.com/en/news/292814054.md)
- [Natera Director Jonathan Sheena Reports Disposal of $478,944.7336 in Common Shares](https://longbridge.com/en/news/305519596.md)
- [What Varex Imaging Buyers Were Betting On](https://longbridge.com/en/news/305520731.md)
- [Mars AI Hub Launch Might Change The Case For Investing In Genpact (G)](https://longbridge.com/en/news/305520548.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**